Status:
COMPLETED
Rheumatic Heart Disease Community Streptococcal Treatment Program "RESET"
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
Uganda Heart Institute
Children's National Research Institute
Conditions:
Rheumatic Heart Disease
Eligibility:
All Genders
5-15 years
Phase:
NA
Brief Summary
The primary objective of this study is to determine the impact of a pragmatic RHD primary prevention program in Uganda. The secondary Objective are as follow: 1. To improve guideline-based care for ...
Detailed Description
Our intervention is designed as a service-oriented plan to be implemented through the primary healthcare structure and facilities of both the national health and private system. Additional support wil...
Eligibility Criteria
Inclusion
- • Has agreed to participate in the study via the study's informed consent/assent process.
Exclusion
- Known history of ARF or RHD
- Any known co-morbid conditions (HIV, renal deficiencies, severe malnutrition,
- among others) that have resulted in prescription of regular antibiotic prophylaxis
- Structural or functional cardiac defects, other than those consistent with RHD, that were known prior to or detected through echo screening (except patent foramen ovale, small atrial septal defect, small ventricular septal defect, small patent ductus arteriosus).
Key Trial Info
Start Date :
January 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
66123 Patients enrolled
Trial Details
Trial ID
NCT05276999
Start Date
January 31 2022
End Date
March 30 2024
Last Update
June 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uganda Heart Institute
Kampala, Uganda